Mayo Clinic
200 1st Street SW
Rochester
Minnesota
55905
United States
Tel: 507-284-2511
Fax: 507-284-0161
Website: http://www.mayo.edu/
880 articles about Mayo Clinic
-
DiviTum(R) TKa in Observational Trial
4/12/2024
Biovica International Biovica, active in cancer monitoring, announces that a observational trial with DiviTum TKa has started at Mayo Clinic in Florida.
-
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
4/4/2024
Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced the launch of an initiative with Mayo Clinic to provide comprehensive genomic profiling and hereditary cancer tests to patients.
-
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
3/28/2024
Exact Sciences Corp. in collaboration with Mayo Clinic Comprehensive Cancer Center, reported on data showing high sensitivity and specificity for the non-endoscopic Oncoguard® Esophagus test that is currently in development for the detection of esophageal adenocarcinoma and its precursors, including Barrett’s esophagus.1,2 Findings from the test’s algorithm training and testing were recently published in the Clinical Gastroenterology and Hepatology journal.
-
PathKeeper Surgical enters into know-how agreement with Mayo Clinic for low-radiation pediatric spine surgery
3/25/2024
PathKeeper Surgical, an Israeli medical technology company committed to advancing surgical solutions through innovative camera and machine learning technologies, announced it has entered into a know-how agreement with Mayo Clinic to research radiation levels in pediatric spine surgeries.
-
Phase III clinical trial of pediatric subjects with PMM2-CDG begins crossover to open label epalrestat
3/18/2024
Maggie's Pearl, a collaboration between Perlara, Maggie's Cure, and the Mayo Clinic, announced that the Phase III trial of oral epalrestat therapy in pediatric subjects with PMM2-CDG (formerly, Congenital Disorder of Glycosylation Type 1a) has been green-lighted to transition to open label.
-
PRECISIO BIOTIX THERAPEUTICS ANNOUNCES COLLABORATION WITH MAYO CLINIC
3/14/2024
Precisio Biotix Therapeutics ("Precisio") today announced it has entered into an agreement with Mayo Clinic.
-
apoQlar enters into Collaboration with Mayo Clinic to Advance Patient Care with Extended Reality Technology
3/12/2024
apoQlar, a pioneer in medical visualization technology, is excited to announce a collaboration with Mayo Clinic aimed at enhancing patient care through the innovative application of extended reality (XR) technology.
-
While GLP-1 drugs have exploded in popularity, they don’t work for everyone, and experts say phenotyping based on a greater understanding of the disease is the future of obesity treatment.
-
SimBioSys and Mayo Clinic Enter Strategic Collaboration to Advance AI-powered Digital Precision Medicine Platform for Cancer Patients
1/2/2024
SimBioSys announced today it has entered into a strategic collaboration agreement with Mayo Clinic for the development of novel digital precision medicine solutions for breast cancer patients.
-
Fresenius Kabi and Mayo Clinic Enter into Multiyear Supply and Service Agreement for the Ivenix® Infusion System
12/14/2023
Fresenius Kabi announced it has signed a multiyear agreement under which the Mayo Clinic is expected to purchase 10,000 Ivenix® large-volume infusion pumps for its hospitals and clinics in Minnesota, Arizona and Florida.
-
Mayo Clinic Laboratories and Progentec® collaborate to bring advanced biomarker testing services to patients with autoimmune diseases
11/14/2023
Mayo Clinic Laboratories and Progentec Diagnostics announced a strategic collaboration to bring Progentec's suite of proprietary biomarker blood tests for the proactive management of autoimmune diseases to market.
-
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care
11/2/2023
BioSig Technologies, Inc. announced that Mayo Clinic-Phoenix has upgraded to the Platform’s subscription model to gain immediate access to the Company’s latest technological advancements in cardiac arrhythmia identification.
-
Clarix Imaging Enters into Know-How Agreement with Mayo Clinic in Surgical Oncology and Radiology
10/26/2023
Clarix Imaging®, a pioneering force in surgical oncology, proudly announces a collaboration with Mayo Clinic to catalyze new surgical advancements using Clarix Imaging’s proprietary and patented volumetric specimen imaging hardware and software technology.
-
Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders
10/19/2023
Mayo Clinic and Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, unveiled a multi-year joint development collaboration to develop new clinical tests for diseases and improve patient care.
-
Perimeter Medical Imaging AI Announces Patient Randomization Underway at Clinical Trial Site at Mayo Clinic in Florida
10/11/2023
Perimeter Medical Imaging AI, Inc. announced that patient randomization is underway at Mayo Clinic in Florida, the most recent clinical site to be initiated as part of an ongoing multi-center, randomized two-arm pivotal clinical trial evaluating the investigational Perimeter B-Series OCT combined with its proprietary ImgAssist AI software.
-
Anumana Receives U.S. FDA 510(k) Clearance for ECG-AI Algorithm to Detect Low Ejection Fraction
10/2/2023
Anumana, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for ECG-AI LEF, a breakthrough artificial intelligence (AI)-powered medical device to detect low ejection fraction (LEF) in patients at risk of heart failure.
-
AccuLine Announces Know-How License Agreement with Mayo Clinic to Advance Early Detection of Heart Attacks
9/28/2023
AccuLine, a digital health startup company, has announced a collaboration with Mayo Clinic through a know-how license agreement for the advancement of CORA, AccuLine's novel solution designed for the early detection of coronary artery disease.
-
Biostage Activated Mayo Clinic as The First Site for Clinical Trial in Severe Esophageal Disease
7/18/2023
Biostage, Inc. today announced that it officially activated the site with Mayo Clinic for its clinical trial as to severe esophageal disease, being its first clinical trial in the United States.
-
Aditxt Subsidiary Adimune Signs Clinical Trial Agreement with Top Research Institution to Study Stiff Person Syndrome
5/5/2023
Aditxt®, Inc. today announces that its subsidiary Adimune™, Inc. (“Adimune”), has signed a clinical trial agreement with Mayo Clinic to advance clinical studies targeting autoimmune diseases.
-
Mayo Clinic Collaborates with Naveris to Advance Precision Medicine in HPV-driven Head and Neck Cancer with NavDx in DART 2.0 Clinical Trial
4/12/2023
Naveris, Inc., a leader in molecular diagnostics for viral cancers, today announced the launch of the DART 2.0 prospective clinical trial (NCT05541016) by Mayo Clinic.